Roche Holding Ltd Stock Annual Yield
| RHHBY Stock | USD 35.39 0.18 0.51% |
Roche Holding Ltd fundamentals help investors to digest information that contributes to Roche Holding's financial success or failures. It also enables traders to predict the movement of Roche OTC Stock. The fundamental analysis module provides a way to measure Roche Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roche Holding otc stock.
Roche |
Roche Holding Ltd OTC Stock Annual Yield Analysis
Roche Holding's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current Roche Holding Annual Yield | 0.03 % |
Most of Roche Holding's fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roche Holding Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Roche Holding Ltd has an Annual Yield of 0.0338%. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The annual yield for all United States stocks is notably lower than that of the firm.
Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Roche Fundamentals
| Return On Equity | 0.45 | |||
| Return On Asset | 0.15 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 293.22 B | |||
| Shares Outstanding | 6.4 B | |||
| Shares Owned By Institutions | 1.27 % | |||
| Price To Earning | 17.56 X | |||
| Price To Book | 9.81 X | |||
| Price To Sales | 3.99 X | |||
| Revenue | 62.8 B | |||
| Gross Profit | 47.83 B | |||
| EBITDA | 22.26 B | |||
| Net Income | 13.93 B | |||
| Cash And Equivalents | 6.81 B | |||
| Cash Per Share | 1.06 X | |||
| Total Debt | 16.08 B | |||
| Debt To Equity | 1.00 % | |||
| Current Ratio | 1.11 X | |||
| Book Value Per Share | 4.38 X | |||
| Cash Flow From Operations | 20.98 B | |||
| Earnings Per Share | 2.40 X | |||
| Price To Earnings To Growth | 3.53 X | |||
| Target Price | 47.8 | |||
| Number Of Employees | 103.61 K | |||
| Beta | 0.19 | |||
| Market Capitalization | 244.36 B | |||
| Total Asset | 92.32 B | |||
| Working Capital | 4.41 B | |||
| Current Asset | 28.15 B | |||
| Current Liabilities | 23.74 B | |||
| Z Score | 9.0 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.98 % | |||
| Net Asset | 92.32 B | |||
| Last Dividend Paid | 9.5 |
About Roche Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Roche Holding Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roche Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roche Holding Ltd based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Roche OTC Stock Analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.